Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative Review - AlSharoqi, IA; Aljumah, M; Bohlega, S (Neurol Ther, 2020)
et al.